Epioxa Provides the Ophthalmic Community and Patients with the First and Only FDA-Approved, IncisionFree, Topical Drug Therapy for Keratoconus Epioxa Represents a Novel, Groundbreaking Therapy
Ken Pullum gave an interesting talk to the Keratoconus Group outlining his ideas for addressing the increasing problem of waiting times for appointments. Not only
By Peter Field HERTFORD UK, APRIL / MAY 2025 at The BEAM theatre complex There is something quite magical when you arrive at Hertford on
By Daniel Morgan-Williams, Founding Director of Visualise Training and Consultancy Working in the workplace adjustment space, we see this quite often. An employee requests an
At our AGM and Speaker meeting both Dr Abass and optometrist Lynn White, carefully explained the progress of their work to find a solution for
We are pleased to report that Dr Ahmed Abass has published his paper which we are proud to have co-sponsored with Fight for Sight. Dr
At our AGM we were treated to a talk by Emma McVeigh about a new project led by Dan Ehrlich (retired Head of Optometry at
As you can see from the Government website (Eye conditions and driving), Keratoconus has been removed from the list of notifiable conditons. This change was
Recently a number of our members have experienced problems when supplied with new scleral contact lenses. Such was the concern that we asked members for
Moorfields have a new service to access it visit: https://www.moorfields.nhs.uk/service/accident-emergency Scroll down to this tab and follow the instructions:
